Rafael J Rivera

What was reported

$10,720.82

in general payments reported to CMS, 2019-2025 · $1,653 in 2025

The $1,653 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

Who reported paying

General payments only, top 6 by amount.

• Medtronic, INC. $1,845.89
• Janssen Pharmaceuticals, INC $1,479.28
• Zoll Services LLC (A/K/A Zoll Lifecor Corp) $1,244.79
• Abbott Laboratories $1,058.37
• Edwards Lifesciences Corporation $902.83
• Astrazeneca Pharmaceuticals LP $693.23

Drugs and devices associated with these payments

Xarelto Lifevest Repatha Jardiance Eliquis Farxiga Symplicity G3 Aveir Vyndaqel Paxlovid Lokelma Opticross

Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.

Questions you might ask

• I saw Rafael Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?
• Is there a generic or alternative to this medication, and would it work as well for me?
• What made you choose this particular treatment for my situation?

These are normal questions. A good clinician will welcome them.